Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 3 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Breast 3Head & Neck 2Thoracic 1Plasma cell 1Lymphoid 1Genitourinary 1

Conditions

Breast Neoplasms 3Pain, Postoperative 2Agnosia 2

Interventions

Trastuzumab 696Paclitaxel 679Cyclophosphamide 634Docetaxel 554Capecitabine 468Letrozole 407Carboplatin 393Fulvestrant 379Doxorubicin 330Tamoxifen 288pembrolizumab 272Anastrozole 252Epirubicin 249exemestane 238pertuzumab 229Bevacizumab 214Radiotherapy 213Gemcitabine 211Vinorelbine 188palbociclib 183Lapatinib 175130-nm albumin-bound paclitaxel 168Albumin-Bound Paclitaxel 156Exercise 147Magnetic Resonance Spectroscopy 145eribulin 144Taxes 134Fluorouracil 131Everolimus 118Cisplatin 118

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Analgesics, Opioid × Breast × Clear all
NCT03471442 2022-07-28

Erector Spinae Plane Block Versus Paravertebral Block

University of Alberta

Phase NA Completed
48 enrolled
Breast

Breast Neoplasms, Pain, Postoperative

NCT00418457 2020-06-16

Regional Anesthesia and Breast Cancer Recurrence

The Cleveland Clinic

Phase 3 Completed
2,108 enrolled 12 charts
Breast

Agnosia, Breast Neoplasms

NCT00519246 2009-03-31

COPTEAM

Nanjing Medical University

Phase 4 Completed
2,000 enrolled
Breast

Agnosia, Breast Neoplasms, Pain, Postoperative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡